Works matching IS 20050380 AND DT 2024 AND VI 35

Results: 236
    1
    2

    Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e117
    By:
    • Kwon, Janice S.;
    • McTaggart-Cowan, Helen;
    • Ferguson, Sarah E.;
    • Samouëlian, Vanessa;
    • Lambaudie, Eric;
    • Guyon, Frédéric;
    • Tidy, John;
    • Williamson, Karin;
    • Gleeson, Noreen;
    • de Kroon, Cor;
    • van Driel, Willemien;
    • Mahner, Sven;
    • Hanker, Lars;
    • Goffin, Frédéric;
    • Berger, Regina;
    • Eyjólfsdóttir, Brynhildur;
    • Jae-Weon Kim;
    • Brotto, Lori A.;
    • Pataky, Reka;
    • Yeung, Shirley S. T.
    Publication type:
    Article
    3
    4

    A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e106
    By:
    • Kensuke Sakai;
    • Wataru Yamagami;
    • Yasunori Sato;
    • Nobuyuki Susumu;
    • Yoshihito Yokoyama;
    • Kazuhiro Takehara;
    • Masaki Mandai;
    • Aikou Okamoto
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e115
    By:
    • Hiroaki Itamochi;
    • Nobuhiro Takeshima;
    • Junzo Hamanishi;
    • Kosei Hasegawa;
    • Motoki Matsuura;
    • Kiyonori Miura;
    • Shoji Nagao;
    • Hidekatsu Nakai;
    • Naotake Tanaka;
    • Hideki Tokunaga;
    • Shin Nishio;
    • Hidemichi Watari;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino;
    • Ai Kato;
    • Ajit Suri;
    • Toshiaki Yasuoka;
    • Kazuhiro Takehara
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e99
    By:
    • Xiaohua Wu;
    • Jihong Liu;
    • Ruifang An;
    • Rutie Yin;
    • Yu Zhang;
    • Huaijun Zhou;
    • Aiqin He;
    • Li Wang;
    • Jieqing Zhang;
    • Ziling Liu;
    • Wei Duan;
    • Jianqing Zhu;
    • Ge Lou;
    • Guilin Chen;
    • Ying Cheng;
    • Fengxia Xue;
    • Sonja Nick;
    • Haiyan Wang;
    • Donghang Li
    Publication type:
    Article
    26
    27

    Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e69
    By:
    • Wijaya, Silvana Talisa;
    • Ngoi, Natalie Y. L.;
    • Loh, Jerold W. Z.;
    • Tuan Zea Tan;
    • Lim, Diana;
    • Khan, Irfan Sagir;
    • Yee Liang Thian;
    • Lai, Alexa;
    • Ang, Bertrand W. L.;
    • Tong, Pearl;
    • Ng, Joseph;
    • Low, Jeffrey J. H.;
    • Ilancheran, Arunachalam;
    • Siew Eng Lim;
    • Yi Wan Lim;
    • Tan, David S. P.
    Publication type:
    Article
    28

    Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e114
    By:
    • Daisuke Aoki;
    • Tsutomu Tabata;
    • Satoshi Yanagida;
    • Toshiaki Nakamura;
    • Eiji Kondo;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e111
    By:
    • Olawaiye, Alexander B.;
    • Jae-Weon Kim;
    • Bagameri, Andrea;
    • Bishop, Erin;
    • Chudecka-Głaz, Anita;
    • Devaux, Alix;
    • Gladieff, Laurence;
    • Gordinier, Mary E.;
    • Korach, Jacob;
    • McCollum, Michael E.;
    • Mileshkin, Linda;
    • Monk, Bradley J.;
    • Nicum, Shibani;
    • Nogueira-Rodrigues, Angélica;
    • Oaknin, Ana;
    • O'Malley, David M.;
    • Orlando, Mauro;
    • Dreiling, Lyndah;
    • Tudor, Iulia C.;
    • Lorusso, Domenica
    Publication type:
    Article
    39
    40
    41

    Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e57
    By:
    • Bo Seong Yun;
    • Kwang-Beom Lee;
    • Keun Ho Lee;
    • Ha Kyun Chang;
    • Joo-Young Kim;
    • Myong Cheol Lim;
    • Chel Hun Choi;
    • Hanbyoul Cho;
    • Dae-Yeon Kim;
    • Yun Hwan Kim;
    • Joong Sub Choi;
    • Chae Hyeong Lee;
    • Jae-Weon Kim;
    • Sang Wun Kim;
    • Yong Bae Kim;
    • Chi-Heum Cho;
    • Dae Gy Hong;
    • Yong Jung Song;
    • Seob Jeon;
    • Min Kyu Kim
    Publication type:
    Article
    42

    Targeting BRAF pathway in low-grade serous ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e104
    By:
    • Perrone, Chiara;
    • Angioli, Roberto;
    • Luvero, Daniela;
    • Giannini, Andrea;
    • Di Donato, Violante;
    • Cuccu, Ilaria;
    • Muzii, Ludovico;
    • Raspagliesi, Francesco;
    • Bogani, Giorgio
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e75
    By:
    • Eun Jung Yang;
    • Jin Lee, A.;
    • Woo Yeon Hwang;
    • Suk-Joon Chang;
    • Hee Seung Kim;
    • Nam Kyeong Kim;
    • Yeorae Kim;
    • Tae Wook Kong;
    • Eun Ji Lee;
    • Soo Jin Park;
    • Joo-Hyuk Son;
    • Dong Hoon Suh;
    • Dong Hee Son;
    • Seung-Hyuk Shim
    Publication type:
    Article
    50